Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders

被引:7
|
作者
Fischer, Kai F. [1 ]
Simon, Maria S. [1 ]
Elsner, Julie [3 ]
Dobmeier, Johanna [4 ]
Dorr, Johannes [5 ]
Blei, Leonie [1 ]
Zill, Peter [1 ]
Obermeier, Michael [2 ]
Musil, Richard [1 ]
机构
[1] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Univ Hosp, Nussbaumstr 7, D-80336 Munich, Germany
[2] GKM Gesell Therapieforsch mbH, Munich, Germany
[3] Univ British Columbia, Inst Mental Hlth UBC, Vancouver, BC, Canada
[4] Endopraxis Amberg, Amberg, Germany
[5] Clin Internal Med South, Munich, Germany
关键词
Childhood trauma; Inflammation; CRP; Depressive disorder; Treatment resistance; BECK DEPRESSION INVENTORY; BODY-MASS INDEX; INFLAMMATORY BIOMARKERS; EPIGENETIC REGULATION; BIPOLAR DISORDER; EXPERIENCES; ABUSE; MALTREATMENT; ADULTS; METAANALYSIS;
D O I
10.1007/s00406-021-01245-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Adverse Childhood Experiences (ACE) are a well-known risk-factor for depression. Additionally, (high-sensitive) C-reactive Protein (hsCRP) is elevated in subgroups of depressed patients and high following ACE. In this context the literature considers hsCRP and ACE to be associated with treatment resistant depression. With the data being heterogenous, this study aimed to explore the associations of ACE, hsCRP levels and response to antidepressant treatment in uni- and bipolar depression. N = 76 patients diagnosed with uni- or bipolar depression and N = 53 healthy controls were included. Treatment was over 6 weeks in an inpatient psychiatric setting within an observatory study design. Depressive symptoms were assessed by the Montgomery-Asberg Depression Rating Scale (MADRS), ACE were assessed by the Childhood Trauma Questionnaire (CTQ); the body-mass-index (BMI) and hsCRP were measured. HsCRP levels did not differ between the study population and the healthy controls. While the depressive symptoms decreased, the hsCRP levels increased. Sexual abuse was associated with significant higher and emotional abuse with lower levels of hsCRP after 6 weeks. The baseline hsCRP levels and the ACE subgroups did not show significant associations with the treatment response in unipolar depressed patients. The long-lasting effects of specific forms of ACE may have relevant impact on inflammation, supporting hsCRP to be a suitable biomarker. With ACE and hsCRP not showing any significant associations with treatment response in the unipolar depressed subgroup, a more differentiate research concerning biomarkers and treatment regimens is needed when talking about treatment response.
引用
收藏
页码:1331 / 1341
页数:11
相关论文
共 50 条
  • [1] Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders
    Kai F. Fischer
    Maria S. Simon
    Julie Elsner
    Johanna Dobmeier
    Johannes Dorr
    Leonie Blei
    Peter Zill
    Michael Obermeier
    Richard Musil
    European Archives of Psychiatry and Clinical Neuroscience, 2021, 271 : 1331 - 1341
  • [2] The emerging role of C-reactive protein in affective and psychotic disorders
    De Berardis, D.
    Serroni, N.
    Cavuto, M.
    Martinotti, G.
    Campanella, D.
    D'Albenzio, A.
    Carano, A.
    Alessandrini, M.
    Farina, B.
    Di Iorio, G.
    Moschetta, F. S.
    Di Giannantonio, M.
    JOURNAL OF PSYCHOPATHOLOGY, 2009, 15 (03): : 231 - 242
  • [3] Cognitive impairment, childhood trauma, sedentary behaviour, and elevated C-reactive protein levels in major affective disorders
    Congio, Ana Carolina
    Urbano, Mariana Ragassi
    Zoega Soares, Maria Rita
    Vargas Nunes, Sandra Odebrecht
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 155 : 1 - 9
  • [4] The relations between C-reactive protein and trauma exposure, PTSD and depression symptoms, and PTSD psychotherapy treatment response in treatment seeking veterans and service members
    Maples-Keller, Jessica L.
    Yasinski, Carly
    Stojek, Monika
    Ravi, Meghna
    Watkins, Laura E.
    Patton, Samantha C.
    Rothbaum, Alex O.
    Unongo, Mbapelen
    Dunlop, Boadie W.
    Rauch, Sheila A. M.
    Michopoulos, Vasiliki
    Rothbaum, Barbara O.
    BRAIN BEHAVIOR AND IMMUNITY, 2022, 101 : 84 - 92
  • [5] The association of C-reactive protein with responses to escitalopram antidepressant treatment in patients with major depressive disorder
    Zhou, Jingjing
    Zhou, Jia
    Sun, Zuoli
    Feng, Lei
    Feng, Yuan
    Xiao, Le
    Chen, Xu
    Yang, Jian
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 306 : 32 - 38
  • [6] Longitudinal associations between circulating interleukin-6 and C-reactive protein in childhood, and eating disorders and disordered eating in adolescence
    Solmi, Francesca
    Bulik, Cynthia M.
    De Stavola, Bianca L.
    Dalman, Christina
    Khandaker, Golam M.
    Lewis, Glyn
    BRAIN BEHAVIOR AND IMMUNITY, 2020, 89 : 491 - 500
  • [7] Observational and mechanistic links between C-reactive protein and blood pressure in elderly women
    Hosford-Donovan, Adrian
    Nilsson, Andreas
    Wahlin-Larsson, Britta
    Kadi, Fawzi
    MATURITAS, 2016, 89 : 52 - 57
  • [8] From Childhood Trauma to Elevated C-Reactive Protein in Adulthood: The Role of Anxiety and Emotional Eating
    Schrepf, Andrew
    Markon, Kristian
    Lutgendorf, Susan K.
    PSYCHOSOMATIC MEDICINE, 2014, 76 (05): : 327 - 336
  • [9] Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder
    Zhang Jun
    Yue Yingying
    Ashok, Thapa
    Fang Jianzhong
    Zhao Shengjun
    Shi Weihua
    Yang Zhong
    Li Yanfang
    Yuan Yonggui
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 250 : 432 - 438
  • [10] Elevated C-reactive Protein Levels in Women with Bipolar Disorder may be Explained by a History of Childhood Trauma, Especially Sexual Abuse, Body Mass Index and Age
    Moraes, Juliana Brum
    Maes, Michael
    Barbosa, Decio Sabbatini
    Ferrari, Thais Zagabria
    Spagolla Uehara, Marcela Keikko
    Carvalho, Andre F.
    Vargas Nunes, Sandra Odebrecht
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (04) : 514 - 521